{{Rsnum
|rsid=7254617
|Gene=AKT2
|Chromosome=19
|position=40285605
|Orientation=plus
|GMAF=0.2158
|Gene_s=AKT2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 23.9 | 73.5
| HCB | 0.7 | 24.8 | 74.5
| JPT | 1.8 | 23.0 | 75.2
| YRI | 17.7 | 39.5 | 42.9
| ASW | 5.3 | 61.4 | 33.3
| CHB | 0.7 | 24.8 | 74.5
| CHD | 2.8 | 25.7 | 71.6
| GIH | 2.0 | 12.9 | 85.1
| LWK | 14.5 | 53.6 | 31.8
| MEX | 1.7 | 31.0 | 67.2
| MKK | 14.1 | 50.0 | 35.9
| TSI | 1.0 | 28.4 | 70.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=22815832
|Title=Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population
|OA=1
}}

{{on chip | Illumina Human 1M}}